Description
Compliance Policy Guide Sec. 230.120- Human Blood and Blood Products As Drugs is obsolete and was withdrawn on 1/30/2020.
Key Topics
Terms and concepts identified from this document
Scope & Applicability
Product Classes
3Drugs
Clinical investigations of drugs, including human drugs and biological products
Biologics
Products for which batch/lot information is particularly important
Human Blood and Blood Products
Human Blood and Blood Products as Drugs
See Also (8)
- CPG Sec. 230.150 Blood Donor Classification Statement, Paid or Volunteer Donor
- CPG Sec. 130.400 Use of Microfiche and/or Microfilm for Method of Records Retention
- CPG Sec. 101.100 FDA Considerations for Recommending Charges for Causing the Introduction of Violative Products into Interstate Commerce
- CPG Sec. 160.600 Payment of Expert Witnesses
- CPG Sec. 110.500 Food and Drug Guaranty - Imports
- Compliance Policy Guides Index
- CPG Sec 590.600 Wigs Compliance Policy Guide 7128.05
- CPG Sec. 140.100 Seizure of Books that Constitute Misleading Labeling